Dr Nicholas Bucknell

Radiation Oncologist
Become a Patient

With more than eight years of radiation oncology experience across three states, Dr Bucknell brings a comprehensive, patient-centred approach to his practice. He is committed to improving indigenous cancer care and ensuring rural and regional cancer patients receive access to the best possible treatment.


Dr Nicholas Bucknell is an experienced radiation oncologist at Icon Cancer Centre Midland. In 2012 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Western Australia and subsequently undertook specialist radiation oncology training in Victoria and Tasmania. Dr Bucknell completed a clinical research fellowship at Peter MacCallum Cancer Centre where he gained extensive experience in managing a broad range of cancer types. In 2021 he became a fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) and undertook a radiation oncology position at Peter MacCallum Cancer Centre.

Dr Bucknell maintains a strong interest in clinical research and trials with a particular focus on lung cancer and stereotactic ablative radiation therapy (SABR). He enjoys a mixture of clinical work, contributing to leading national and international publications and conferences, and attending regular multidisciplinary meetings with his colleagues. In addition to his role at Icon, Dr Bucknell is a radiation oncologist at Sir Charles Gairdner Hospital. He is also a member of several leading cancer trial groups including the American Society of Radiation Oncology (ASTRO), European Society for Radiotherapy and Oncology (ESTRO) and Trans Tasman Oncology Group (TROG). Dr Bucknell has been awarded a number of RANZCR prizes and research grants including the Varian Prize for best trainee oral presentation at the 2018 annual scientific meeting and the Withers and Peters Scholarship in 2021.

His clinical experience covers a broad range of solid tumour malignancies with a special interest in lung cancer, gastrointestinal cancer, colorectal cancer, skin cancer, brain cancer and spinal (CNS), and stereotactic radiation therapy.

Affiliations & Memberships

  • American Society for Radiation Oncology (ASTRO)
  • Co-operative Trials Group for Neuro-oncology (COGNO)
  • European Society for Radiotherapy and Oncology (ESTRO)
  • International Association for the Study of Lung Cancer (IASLC)
  • International Stereotactic Radiosurgery Society (ISRS)
  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • Thoracic Oncology Group of Australasia (TOGA)
  • Trans Tasman Radiation Oncology Group (TROG)

Special Interests

Dr Nicholas Bucknell accepts referrals for all cancer types, with a special clinical interest in:
  • Brain and spine (CNS) cancer
  • Gastrointestinal cancer
  • Lung cancer
  • Skin cancer
  • Stereotactic radiation therapy

Icon Locations

Midland View centre

Visiting Locations

  • Sir Charles Gairdner Hospital


  • Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors. N. Bucknell, D. Gyorki, M. Bressel, V. Estall, A. Webb, M. Henderson, M. Chua, D. Rischin & A. Tiong. Australasian Journal of Dermatology, 2022; 63(1): 43-52.

  • Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer. N. Bucknell, N. Hardcastle, P. Jackson, M. Hofman, J. Callahan, P. Eu, A. Iravani, R. Lawrence, O. Martin, M. Bressel, B. Woon, B. Blyth, M. Macmanus, K. Byrne, D. Steinfort, T. Kron, G. Hanna, D. Ball & S. Siva. BMJ Open, 2020; 10(12): e042465.

  • Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus. Y. Freifeld, I. Pedrosa, M. Mclaughlin, R. Correa, A. Louie, J. Maldonado, C. Tang, B. Kadow, A. Kutikov, R. Uzzo, C. Porta, N. Bucknell, S. Siva, J. Brugarolas, V. Margulis, R. Timmerman & R. Hannan. Urologic Oncology: Seminars and Original Investigations, 2022; 40(4): e9-166.e13.

  • Monitoring DNA Damage and Repair in Peripheral Blood Mononuclear Cells of Lung Cancer Radiotherapy Patients. P. Lobachevsky, N. Bucknell, J. Mason, D. Russo, X. Yin, L. Selbie, D. Ball, T. Kron, M. Hofman, S. Siva & O. Martin, Olga. (2020). Cancers, 2020; 12(9): 2517.

  • Long-term Survival with 18-Fluorodeoxyglucose Positron Emission Tomography-directed Therapy in Non-small Cell Lung Cancer with Synchronous Solitary Brain Metastasis. S. Newman, N. Bucknell, M. Bressel, P. Tran, B. Campbell, S. David, N. Haghighi, G. Hanna, D. Kok, M. MacManus, C. Phillips, N. Plumridge, M. Shaw, A. Wirth, G. Wheeler, D. Ball & S. Siva. Clinical Oncology, 2020; 33(3): 161-171.